Genomic surveillance of emerging SARS-CoV-2 Omicron variations in Tianjin Municipality, China 2022

• Egile Nagusiak: Xin Gao (Egilea), Ming Zou (Egilea), Yue Lei (Egilea), Zhaolin Tan (Egilea), Zhichao Zhuang (Egilea), Baolu Zheng (Egilea), Aiping Yu (Egilea), Yanzhen Han (Egilea), Xiaohui Lu (Egilea), Xiaochang Liu (Egilea), Ying Wang (Egilea), Yuan Wang (Egilea), Liru Guo (Egilea), Guangwen Liu (Egilea), Wen Li (Egilea), Yang Liu (Egilea), Likun Lv (Egilea), Peiyong Ning (Egilea), Xiaoyan Li (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2024-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has severely impacted public health. In 2022, the Omicron variant of SARS-CoV-2 rapidly became the dominant circulating variant in the local COVID-19 outbreaks in Tianjin Municipal...